1 to 10 of 11 literature results

• Hypertriglyceridaemia with bexarotene in cutaneous T cell lymphoma: the role of omega-3 fatty acids.

  Bexarotene is approved for the treatment of cutaneous T cell lymphomas in patients refractory to at least one prior systemic therapy. Associated hyper…

  Authors: Antonino Musolino, Michele Panebianco, Enrico Zendri, Marcello Santini, Sergio Di Nuzzo, Andrea Ardizzoni

  Source: British journal of haematology. 2009 Apr

  View Full Text

• Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.

  BACKGROUND: The current study was designed to assess the activity and safety of a novel combination therapy for patients with recurrent or refractory …

  Authors: Antonino Musolino, Maria Antonietta Perrone, Maria Michiara, Daniela Delnevo, Vittorio Franciosi, Beatrice Di Blasio, Guido Ceci, Roberta Camisa, Andrea Ardizzoni, Giorgio Cocconi

  Source: Cancer. 2005 May 15

  View Full Text

• A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes.

  We report the first case in Italy of a non-Ashkenazi double heterozygote for BRCA1 and BRCA2 genes. This finding is predictably rare, with a maximum f…

  Authors: Antonino Musolino, Nadia Naldi, Maria Michiara, Maria A Bella, Paola Zanelli, Beatrice Bortesi, Marzia Capelletti, Mario Savi, Tauro M Neri, Andrea Ardizzoni

  Source: Breast cancer research and treatment. 2005 May

  View Full Text

• Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.

  PURPOSE: The anti-HER-2/neu monoclonal antibody trastuzumab has been shown to engage both activatory (fragment C receptor [Fc gamma R]IIIa; Fc gamma R…

  Authors: Antonino Musolino, Nadia Naldi, Beatrice Bortesi, Debora Pezzuolo, Marzia Capelletti, Gabriele Missale, Diletta Laccabue, Alessandro Zerbini, Roberta Camisa, Giancarlo Bisagni,…

  Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Apr 10

  View Full Text

• BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

  Early age at onset is generally considered an indicator of genetic susceptibility to breast cancer. To address both the proportion of early-onset brea…

  Authors: Antonino Musolino, Maria A Bella, Beatrice Bortesi, Maria Michiara, Nadia Naldi, Paola Zanelli, Marzia Capelletti, Debora Pezzuolo, Roberta Camisa, Mario Savi,…

  Source: Breast (Edinburgh, Scotland). 2007 Jun

  View Full Text

• Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study.

  PURPOSE: To evaluate the clinical features of breast cancer patients with genetic susceptibility to this disease and to investigate the contribution o…

  Authors: Antonino Musolino, Maria Michiara, Maria A Bella, Nadia Naldi, Paola Zanelli, Beatrice Bortesi, Marzia Capelletti, Linda Soldani, Roberta Camisa, Eugenia Martella,…

  Source: Tumori. 2005 Nov-Dec

  View Full Text

• Retrospective study of resection of pulmonary metastases in patients with advanced colorectal cancer: the development of a preoperative chemotherapy strategy.

  Considerable data are available to support the resection of hepatic metastases in patients with colorectal cancer, but there are relatively few studie…

  Authors: Francesca Negri, Antonino Musolino, David Cunningham, Ugo Pastorino, George Ladas, Andrew R Norman

  Source: Clinical colorectal cancer. 2004 Jul

  View Full Text

• Early detection of recurrences in the follow-up of primary breast cancer in an asymptomatic or symptomatic phase.

  AIMS AND BACKGROUND: Periodic follow-up after primary treatment for breast cancer is a common procedure for the early detection of recurrent disease i…

  Authors: Maria Antonietta Perrone, Antonino Musolino, Maria Michiara, Beatrice Di Blasio, Mariangela Bella, Vittorio Franciosi, Giorgio Cocconi, Roberta Camisa, Renata Todeschini, Stefano Cascinu

  Source: Tumori. 2004 May-Jun

  View Full Text

• Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity.

  OBJECTIVES: The value of HER-2/neu status as a predictor of response to anthracycline-based chemotherapy is still a matter of debate. We evaluated the…

  Authors: Cecilia Bozzetti, Antonino Musolino, Roberta Camisa, Giancarlo Bisagni, Marcella Flora, Cristina Bassano, Eugenia Martella, Costanza Lagrasta, Rita Nizzoli, Nicola Personeni,…

  Source: American journal of clinical oncology. 2006 Apr

  View Full Text

• p73 and p53 pathway in human breast cancers.

  Authors: Cecilia Bozzetti, Rita Nizzoli, Antonino Musolino, Eugenia M Martella, Pellegrino Crafa, Costanza A Lagrasta, Roberta Camisa, Antonio Bonati, Paolo Lunghi, Andrea Ardizzoni

  Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Apr 10

  View Full Text